World's first optical instrument to observe cancer cells in 4-D

World's first optical instrument to observe cancer cells in 4-D
Credit: Heriot-Watt University

A new optical instrument to help scientists observe live cells in 4-D and understand what triggers them to mutate and spread disease around the human body has received close to £1m in funding.

The collaborative three-year project, led by the University of Nottingham, will involve expert partners from Heriot-Watt University and the University of Glasgow.

The research will result in a bespoke instrument, combining four cutting-edge optical microscopy technologies in a way that has not been previously possible, creating a single multifunctional platform.

The tool will, for the first time, image in 4-D, to plot, track and analyse the cells' position, movement and function as they grow into and interact with the proteins and sugars that make up their surrounding environment (the extracellular matrix).

This will enable scientists to understand how physical and biochemical cues from cells influence the matrix, and vice versa, and how these interactions affect the progression of disease.

Dr. Amanda Wright, Project Lead from the University of Nottingham, said: "This instrument will revolutionise our understanding of how cells respond to the forces imposed on them by their matrix as they move through it—forces which directly control cell function and behaviour.

"For the first time, we will be able to view the cellular microworld from a cell's own perspective. It will help us to learn how migrating cancer cells, for example, exploit existing tracts and directional cues inside the matrix."

Dr. Paul Dalgarno from Heriot-Watt University who pioneered a multiplane imaging technique that underpins the new instrument, said: "While a conventional microscope produces a sharp image from just a single object-plane, multiplaning records sharp images from several object-planes simultaneously.

"We will combine our revolutionary multiplane system with optical trapping before integrating this into the full light sheet based trapping system of our co-collaborators. Together this will enable us to fully study how cells migrate, grow and interact in 3-D and in real time."

The new approach will be important for developing therapies for diseases where cells respond abnormally to signals from their local matrix, such as cancer. The advancement in optical technology could also benefit research into degenerative diseases, regenerative medicine and infection pathways as scientists build a better understanding that will ultimately inform treatments.

A second research strand will examine how cells absorb particles and the impact that drug therapies (such as functionalised polymer nanoparticles) have on the matrix. The findings could help to design new medicines and drug delivery systems targeted at the macromolecular level.

Commenting on the collaboration, Professor John Underhill, Chief Scientist at Heriot-Watt University, said: "This million pound investment in life sciences research is a demonstration of the potential and importance of collaboration in research in general and this exciting research theme in particular.

"At Heriot-Watt University, we pride ourselves on being an international university with a global outlook, finding solutions to challenges with wide ranging applications. Our cutting-edge research into microscopy could have wide reaching implications for the treatment of some of the world's biggest killer diseases including cancer."


Explore further

3-D modelling unlocks insight into cancer progression

Citation: World's first optical instrument to observe cancer cells in 4-D (2018, August 13) retrieved 21 July 2019 from https://phys.org/news/2018-08-world-optical-instrument-cancer-cells.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
3 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more